Literature DB >> 29017000

Visual and Postural Motion-Evoked Dizziness Symptoms Are Predominant in Vestibular Migraine Patients.

Doga Vuralli1, Funuzar Yildirim1, Didem T Akcali2, Mustafa N Ilhan3, Nebil Goksu4, Hayrunnisa Bolay1.   

Abstract

Background: Vestibular migraine (VM) is one of the most common underdiagnosed disorders. We aimed to study the clinical characteristics of VM patients who were referred to a neurology-headache unit by otolaryngology after exclusion of peripheral causes of vertigo.
Methods: One hundred and one patients diagnosed with VM in the headache unit were included. Description of vestibular symptoms, demographic and clinical features, trigger factors, accompanying diseases, and response to vestibular-suppressant medications and prophylactic migraine treatment were evaluated.
Results: Vestibular symptoms were triggered by daily head and body movements and mainly consisted of brief attacks lasting seconds (60.4% of patients) although the total duration of the vestibular episode lasted hours or days. Other aggravating factors were moving visual stimuli, passive motion, and visually busy environments. Visually induced vestibular symptoms were defined by 71.3% of the patients, and positional motion-induced vestibular symptoms were described by 82.2% of the patients. Vestibular symptoms were mainly defined as feeling the ground slipping from under their feet (40.6%), feeling like there is an earthquake or swaying (27.7%), sensation of rocking on a boat (26.7%), and sensation as if stepping on empty space (24.8%). The majority of the patients (83.2%) previously used vestibular-suppressant drugs, and these drugs were effective temporarily only in 12.9%. Conclusions: Chronic recurrent dizziness symptoms, rather than internal or external vertigo, are predominant in our VM patients. Recurrent brief dizziness attacks induced upon routine visual and/or postural motion, longstanding symptoms with limited response to vestibular suppressants, and precipitation by typical migraine triggers are suggestive of VM.
© 2017 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Diagnosis; Dizziness; Motion; Vertigo; Vestibular Migraine; Visual System

Mesh:

Year:  2018        PMID: 29017000     DOI: 10.1093/pm/pnx182

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  6 in total

Review 1.  Vestibular Migraine.

Authors:  Shin C Beh
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-31       Impact factor: 6.030

2.  The effects of visual context on visual-vestibular mismatch revealed by electrodermal and postural response measures.

Authors:  Doaa S Al-Sharif; Carole A Tucker; Donna L Coffman; Emily A Keshner
Journal:  J Neuroeng Rehabil       Date:  2022-10-20       Impact factor: 5.208

3.  Temporal Patterns of Vertigo and Migraine in Vestibular Migraine.

Authors:  Manyun Yan; Xiaoning Guo; Wei Liu; Jiajie Lu; Jingwen Wang; Lan Hu; Kaijian Xia; Jianqiang Ni; Haifeng Lu; Hongru Zhao
Journal:  Front Neurosci       Date:  2020-04-15       Impact factor: 4.677

4.  Altered Processing of Visual Stimuli in Vestibular Migraine Patients Between Attacks: A Combined VEP and sLORETA Study.

Authors:  Jiahao Liu; Qi Zhang; Maojin Liang; Yajing Wang; Yuebo Chen; Junbo Wang; Jiahong Li; Ling Chen; Leyin Yu; Yinglin Cai; Yiqing Zheng; Yongkang Ou
Journal:  Front Hum Neurosci       Date:  2021-12-24       Impact factor: 3.169

5.  Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model.

Authors:  Ruimin Tian; Yun Zhang; Qi Pan; Yunfeng Wang; Qianwen Wen; Xiaoping Fan; Guangcheng Qin; Dunke Zhang; Lixue Chen; Yixin Zhang; Jiying Zhou
Journal:  J Headache Pain       Date:  2022-03-08       Impact factor: 7.277

6.  Development and Validation of the Predictive Model for the Differentiation between Vestibular Migraine and Meniere's Disease.

Authors:  Dan Liu; Zhaoqi Guo; Jun Wang; E Tian; Jingyu Chen; Liuqing Zhou; Weijia Kong; Sulin Zhang
Journal:  J Clin Med       Date:  2022-08-14       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.